Concepedia

Matthew G. Fury

MG

Statistics

Publications

102

Citations

8.2K

H-Index

48

Active since

1996

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Regeneron (United States)

The University of Texas MD Anderson Cancer Center

Cornell University

Peter MacCallum Cancer Centre

Matthew G. Fury is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

1996–2025

102

Publications

102

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

, , +17

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

Michael R. Migden, Nikhil I. Khushalani, Anne Lynn S. Chang et al. · The Lancet Oncology · 2020 · 480 citations · Full text

, , +13

A 14-Year Retrospective Review of Angiosarcoma

Matthew G. Fury, Cristina R. Antonescu, Kimberly J. Van Zee et al. · The Cancer Journal · 2005 · 418 citations

, , +12

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Neil D. Gross, David M. Miller, Nikhil I. Khushalani et al. · New England Journal of Medicine · 2022 · 309 citations

, , +17

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

Alexander Stratigos, Aleksandar Sekulić, Ketty Peris et al. · The Lancet Oncology · 2021 · 278 citations · Full text

, , +14

1–5 of 102